EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Deciphering the folate puzzle: Unraveling the impact of genetic variations and metabolites on cancer risk

Tong Liu, Chen-An Liu, Ya-Ping Wei, Meng-Meng Song iD, Qi Zhang, Yun Song, Ping Chen, Li-Shun Liu, Bin-Yan Wang, Han-Ping Shi iD

International Journal of Cancer · 2024

DOI: 10.1002/ijc.35043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2024. Verfasst von Tong Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Methylenetetrahydrofolate Reductase (NADPH2), Folic Acid, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key Research and Development Program, National Multidisciplinary Cooperative Diagnosis and Treatment Capacity Project for Major Diseases: Comprehensive Treatment and Management of Critically Ill El…, Laboratory for Clinical Medicine, Capital Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The C677T polymorphism in the MTHFR gene and its role in folate metabolism, impacting serum folate metabolites like THF and 5‐MTHF, is a critical but underexplored area in cancer research. This nested case–control study utilized data from CHHRS, involving 87,492 hypertensive adults without prior cancer. During a median of 2.02 years, we identified 1332 cancer cases and matched controls based on age, sex, and residency. Serum levels of folate, THF, and 5‐MTHF were measured, and the MTHFR C677T gene polymorphism was considered. Statistical analyses included restricted cubic spline regression and conditional logistic regression models. Serum THF levels were inversely associated with overall cancer risk (OR per SD = 0.90, 95% CI = 0.82–0.99), while 5‐MTHF levels showed a negative association in the general cohort (OR Q3 vs. Q1 = 0.76, 95% CI = 0.60–0.96; OR Q4 vs. Q1 = 0.75, 95% CI = 0.58–0.98) and in individuals with MTHFR C677T (CC + CT) polymorphism (OR per SD = 0.87, 95% CI = 0.77–0.99; OR Q4 VS. Q1 = 0.79, 95% CI = 0.61–0.98), but a positive association in the MTHFR C677T (TT) subgroup (OR per SD = 1.89, 95% CI = 1.02–3.72; OR Q4 VS. Q1 = 2.17, 95% CI = 1.06–8.21). The impact of folate, THF, and 5‐MTHF on cancer risk varied significantly across different cancer types and MTHFR C677T genotypes. This study provides novel insights into the variable effects of folate and its metabolites on cancer risk, influenced by genetic factors like the MTHFR C677T polymorphism and cancer type.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methylenetetrahydrofolate Reductase (NADPH2)Folic AcidNeoplasmsHumansFemaleMaleCase-Control StudiesMiddle AgedAgedGenetic Predisposition to DiseasePolymorphism, Single NucleotideRisk FactorsTetrahydrofolatesAdultGenotype

Stichwörter der Autor:innen

5‐MTHFMTHFR C677Tcancerfolatetetrahydrofolate

Substanzen

Methylenetetrahydrofolate Reductase (NADPH2)Folic AcidMTHFR protein, humanTetrahydrofolates5-methyltetrahydrofolate5,6,7,8-tetrahydrofolic acid

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
  • National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, China.
  • Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China.
  • Laboratory for Clinical Medicine, Capital Medical University, Beijing, China.
  • College of Public Health, Shanghai University of Medicine and Health Sciences, Shanghai, China.
  • Cardiovascular Research Institute, University of California, San Francisco, California, USA.

ORCID-Profile: Meng-Meng Song, Han-Ping Shi

Förderung

  • National Key Research and Development Program
  • National Multidisciplinary Cooperative Diagnosis and Treatment Capacity Project for Major Diseases: Comprehensive Treatment and Management of Critically Ill El…
  • Laboratory for Clinical Medicine, Capital Medical University
  • Chinese Polar Environment Comprehensive Investigation and Assessment Programmes

Zitieren

APA

Liu, T., Liu, C. A., Wei, Y. P., Song, M. M., Zhang, Q., Song, Y., Chen, P., Liu, L. S., Wang, B. Y., & Shi, H. P. (2024). Deciphering the folate puzzle: Unraveling the impact of genetic variations and metabolites on cancer risk. International Journal of Cancer. https://doi.org/10.1002/ijc.35043

Vancouver

Liu T, Liu CA, Wei YP, Song MM, Zhang Q, Song Y, et al. Deciphering the folate puzzle: Unraveling the impact of genetic variations and metabolites on cancer risk. International Journal of Cancer. 2024. doi:10.1002/ijc.35043

BibTeX
@article{Liu2024,
  author = {Liu, Tong and Liu, Chen-An and Wei, Ya-Ping and Song, Meng-Meng and Zhang, Qi and Song, Yun and Chen, Ping and Liu, Li-Shun and Wang, Bin-Yan and Shi, Han-Ping},
  title = {Deciphering the folate puzzle: Unraveling the impact of genetic variations and metabolites on cancer risk},
  journal = {International Journal of Cancer},
  year = {2024},
  doi = {10.1002/ijc.35043}
}
Kostenlos starten →